Results: Most invasive breast carcinoma patients were among the age of 50 - 59 (39.6%), invasive ductal carcinoma (82.3%), tumor size ≤2 cm (54.2%), histological grade II (60.2%), lymph node metastasis (53.1%), disease stage II (51%); ER (+) 46.9%, PR (+) 49.0%, Ki-67 (+) 77.1%, HER2 (+) 30.2% of cases.